Michael Lanuti

9PUBLICATIONS
37CO-AUTHORS
Liquid biopsiesMycologyEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 24, 2024
Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis.

Yongtao Wang, Ben Leaker, Guoliang Qiao

|May 15, 2024
Microscopic Small Airway Abnormalities Identified in Early Idiopathic Pulmonary Fibrosis In Vivo Using Endobronchial Optical Coherence Tomography.

Sarita R Berigei, Sreyankar Nandy, Satomi Yamamoto

|Nov 03, 2021
Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer Survival.

Qianyu Yuan, Mulong Du, Elizabeth Loehrer

|Jul 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas.

Jennifer Y Wo, Jeffrey W Clark, Christine E Eyler

|Jun 10, 2021
Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.

Eric W Zhang, Jo-Anne O Shepard, Anderson Kuo

|Jul 03, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI.

Derek J Erstad, Mozhdeh Sojoodi, Martin S Taylor

Pageof 2

Frequent Collaborators

3 joint publications

Derek J Erstad

3 joint publications

Bryan C Fuchs

2 joint publications

Peter Caravan

2 joint publications

Mozhdeh Sojoodi